AI Verdict
INOD has stronger fundamentals based on our AI analysis.
INOD vs INO Fundamental Comparison
| Metric | INOD | INO |
|---|---|---|
| Revenue | $251.7M | $65,343.0 |
| Net Income | $32.2M | $-84.9M |
| Net Margin | 12.8% | -130,000.0% |
| ROE | 30.0% | -352.5% |
| ROA | 19.1% | -114.3% |
| Current Ratio | 2.68x | 1.40x |
| Debt/Equity | 0.06x | 2.60x |
| EPS | $0.92 | $-1.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
INOD vs INO: Frequently Asked Questions
Is INOD or INO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INOD has stronger fundamentals. INOD is rated STRONG BUY (85% confidence) while INO is rated STRONG SELL (92% confidence). This is not investment advice.
How does INOD compare to INO fundamentally?
INNODATA INC has ROE of 30.0% vs INOVIO PHARMACEUTICALS, INC.'s -352.5%. Net margins are 12.8% vs -130,000.0% respectively.
Which stock pays higher dividends, INOD or INO?
INOD has a dividend yield of N/A or no dividend while INO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in INOD or INO for long term?
For long-term investing, consider that INOD has STRONG BUY rating with 85% confidence, while INO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about INOD vs INO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For INOD vs INO, the AI consensus favors INOD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.